Industry Reports >> Pharmaceuticals and Healthcare

 
Single User license
$1,995.00
Site license
$3,990.00
Global license
$5,985.00
 

Healthcare, Regulatory and Reimbursement Landscape - Singapore

By:
, Published: Mar-2012
Report Code: GDHC0013CHR    Report Format: Electronic PDF

Description


GlobalData, the industry analysis specialist, has released its report, “Healthcare, Regulatory and Reimbursement Landscape - Singapore”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of Singapore. The report identifies the key trends in the healthcare market of Singapore. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Singapore. Most importantly, the report provides valuable insights on the trends and segmentation of pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts. Singapore is a country with a population of approximately 5.1 million in 2010. The population growth rate was lower, at 1.8%, in 2010. Low population growth rate and rising elderly population represent a challenge to Singapore. The pharmaceutical market in Singapore was approximately $375m in 2010. It may grow at a Compound Annual Growth Rate (CAGR) of 5.6% and is projected to reach approximately $845m in 2020. The major factors contributing the growth of pharmaceutical market of Singapore include: Efficient intellectual property protection Development of a biomedical industrial park Universal access to insurance plans Reliable healthcare system Incentives offered by the government of Singapore to the multinational biomedical companies to establish their production and research units in the country

Scope

  • Overview of the pharmaceutical and medical devices market of Singapore including the market size, market segmentation, key drivers and barriers for the market.
  • Profile and SWOT analysis of the major players in the pharmaceutical and medical devices market.
  • Insightful review on the reimbursement and regulatory landscape. Analysis includes details of the healthcare reimbursement process, regulatory agencies and market authorization process for new drug and medical devices for Singapore.
  • A detailed analysis of the political and economic environment of Singapore including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
  • An overview of the opportunities and challenges for growth that exist in the healthcare market of Singapore.

Reasons to Buy

  • Develop business strategies by understanding the trends shaping and driving the healthcare market of Singapore.
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the Singaporean healthcare market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market of Singapore.